Showing 261 - 280 results of 548 for search '"inherited metabolic diseases"', query time: 0.47s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264

    Biochemical, Molecular, and Clinical Characterization of Patients With Primary Carnitine Deficiency via Large-Scale Newborn Screening in Xuzhou Area by Wei Zhou, Huizhong Li, Ting Huang, Yan Zhang, Chuanxia Wang, Maosheng Gu

    Published 2019-02-01
    “…The aim of this study was to the clinical, biochemical, and molecular characteristics of PCD patients via newborn screening with tandem mass spectrometry (MS/MS).Methods: MS/MS was performed to screen newborns for inherited metabolic diseases. SLC22A5 gene mutations were detected in the individual and/or their family member by DNA mass array and next-generation sequencing (NGS).Results: Among the 236,368 newborns tested, ten exhibited PCD, and six others were diagnosed with low carnitine levels caused by their mothers, who had asymptomatic PCD. …”
    Get full text
    Article
  5. 265

    Neuroinflammatory paradigms in lysosomal storage diseases by Megan Elizabeth Bosch, Tammy eKielian

    Published 2015-10-01
    “…Lysosomal storage diseases (LSDs) include approximately 70 distinct disorders that collectively account for 14% of all inherited metabolic diseases. LSDs are caused by mutations in various enzymes/proteins that disrupt lysosomal function, which impairs macromolecule degradation following endosome-lysosome and phagosome-lysosome fusion and autophagy, ultimately disrupting cellular homeostasis. …”
    Get full text
    Article
  6. 266

    Acute hepatic porphyria - classification, diagnosis and treatment by Aleksandra Czekaj, Kinga Ruszel, Robert Dubel, Julia Dubel, Natalia Namroży

    Published 2022-11-01
    “… Porphyrias belong to the group of inherited metabolic diseases. Each of the four types of acute hepatic porphyria is caused by a different mutation in the gene of an enzyme involved in the heme biosynthetic pathway. …”
    Get full text
    Article
  7. 267
  8. 268

    Spectrum of Paediatric Lysosomal Storage Disorders in Oman by Almundher A Al-Maawali, Surendra N Joshi, Roshan L Koul, Ali A Al-Maawali, Hilal S Al-Sedari, Bader M Al-Amri, Amna M Al-Futaisi

    Published 2012-08-01
    “…Lysosomal storage disorders (LSDs) are a heterogeneous group of inherited metabolic diseases. Few studies on the birth prevalence and prevalence of LSDs have been reported from the Arabian Peninsula. …”
    Get full text
    Article
  9. 269
  10. 270

    Personalized whole‐body models integrate metabolism, physiology, and the gut microbiome by Ines Thiele, Swagatika Sahoo, Almut Heinken, Johannes Hertel, Laurent Heirendt, Maike K Aurich, Ronan MT Fleming

    Published 2020-05-01
    “…We also illustrate that the WBM models can predict known biomarkers of inherited metabolic diseases in different biofluids. Predictions of basal metabolic rates, by WBM models personalized with physiological data, outperformed current phenomenological models. …”
    Get full text
    Article
  11. 271

    Report of a Rare Syndromic Retinal Dystrophy: Asphyxiating Thoracic Dystrophy (Jeune Syndrome) by Batuhan Aksoy, Gülipek Tigrel

    Published 2025-02-01
    “…Most, if not all, hereditary syndromic retinopathies can be analyzed in two main groups: inherited metabolic diseases and ciliopathies. The main cause of ocular pathologies in JS is genetic mutations in ciliary proteins that prevent normal function of retinal photoreceptor cells. …”
    Get full text
    Article
  12. 272

    GM2-gangliosidosis, type I (Tay – Sachs disease) in the pediatrician practice by Natalia V. Zhurkova, Nato D. Vashakmadze, Natella V. Sukhanova, Olga B. Gordeeva, Natalia S. Sergienko, Ekaterina Yu. Zaharova

    Published 2021-01-01
    “…Differential diagnosis of this disease should be performed with other diseases from the group of inherited metabolic diseases associated with early regression of psychomotor skills, progressive vision loss, “cherry red spot” symptom on the fundus of the eye and convulsive disorder…”
    Get full text
    Article
  13. 273

    Mucopolysaccharidosis Type IIIE: A Real Human Disease or a Diagnostic Pitfall? by Karolina Wiśniewska, Jakub Wolski, Magdalena Żabińska, Aneta Szulc, Lidia Gaffke, Karolina Pierzynowska, Grzegorz Węgrzyn

    Published 2024-08-01
    “…Specific difficulties in diagnostics and the classification of some inherited metabolic diseases are also highlighted and discussed.…”
    Get full text
    Article
  14. 274
  15. 275

    Changes in expression of signal transduction-related genes, and formation of aggregates of GPER1 and OXTR receptors in mucopolysaccharidosis cells by Karolina Pierzynowska, Magdalena Żabińska, Lidia Gaffke, Zuzanna Cyske, Grzegorz Węgrzyn

    Published 2022-06-01
    “…Mucopolysaccharidoses (MPS) are inherited metabolic diseases caused by storage of glycosaminoglycans (GAGs), however, various modulations of the course of these diseases were identified recently due to impairment of different cellular processes. …”
    Get full text
    Article
  16. 276
  17. 277

    A Korean child diagnosed with malonic aciduria harboring a novel start codon mutation following presentation with dilated cardiomyopathy by Seung Hoon Lee, Jung Min Ko, Mi‐Kyoung Song, Junghan Song, Kyung Sun Park

    Published 2020-09-01
    “…Newborn screening for inherited metabolic diseases showed a normal result; therefore, DCMP management was initiated. …”
    Get full text
    Article
  18. 278

    Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses by Valeria De Pasquale, Patrizia Sarogni, Valeria Pistorio, Giuliana Cerulo, Simona Paladino, Luigi Michele Pavone

    Published 2018-09-01
    “…Mucopolysaccharidoses (MPSs) are inherited metabolic diseases caused by the deficiency of lysosomal enzymes needed to catabolize glycosaminoglycans (GAGs). …”
    Get full text
    Article
  19. 279
  20. 280